Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

NCT02243293

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

NCT01685203

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

NCT02582632

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

NCT02023112

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

NCT02640157

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

NCT02247401

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs

NCT02755402

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Centre hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Completed

Truenat™ HCV RNA Assay Evaluation

NCT04236973

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Aarhus University Hospital Aarhus, Denmark

St Paul's Hospital Millennium Medical College Addis Ababa, Ethiopia

National Centre for Diseases Control Tbilisi, Georgia

HIV-NAT Thai Red Cross AIDS Research Centre Bangkok, Thailand

View Trial Details

Completed

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

NCT03652675

Conditions: Acquired Immunodeficiency Syndrome, Alcohol Drinking, Alcohol Use Disorder, +30 more
Locations: NewYork-Presbyterian / Columbia University Medical Center New York, United States

View Trial Details

Completed

Effect of DAAs on Behavior of HCC in HCV Patients

NCT03200171

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
Locations: MOHAMED Alboraie Cairo, Egypt

Helwan University Cairo, Egypt

National Hepatology and Tropical Medicine Research Institute Cairo, Egypt

View Trial Details